NASDAQ:KRON
Delisted

Kronos Bio Stock Predictions

etoro logo Buy KRON
*Your capital is at risk
$0.88
+0 (+0%)
At Close: Sep 19, 2025
Currently predicting for Mon, 8 Jun 2026

KRON Prediction Chart

KRON Predictions History

Latest community submissions for KRON.
Predictor Target Session Target Price Result Direction Accuracy Score
Aug 4, 2023 $1.76 +2.12% $1.71 X 97.28% 0
JS JS Pro
Aug 4, 2023 $1.69 -1.74% $1.71 V 98.83% 2
Aug 3, 2023 $1.83 +3.38% $1.72 X 93.62% 0
Aug 3, 2023 $1.81 +2.11% $1.72 X 94.92% 0
JS JS Pro
Aug 3, 2023 $1.76 -0.56% $1.72 V 97.67% 1
Aug 2, 2023 $1.85 +3.29% $1.77 X 95.55% 0
Aug 2, 2023 $1.83 +2.05% $1.77 X 96.79% 0
JS JS Pro
Aug 2, 2023 $1.77 -1.12% $1.77 V 100.00% 10
Aug 1, 2023 $1.86 -3.07% $1.79 V 96.03% 1
Aug 1, 2023 $1.96 +1.92% $1.79 X 90.68% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for KRON with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT KRONOS BIO INC.
Kronos Bio
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally administered, selective spleen tyrosine kinase inhibitor for acute myeloid leukemia patients. The comp...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
4.09% May 06
GLBE
$31.61
1.65% May 05
SAP
$172.39
7.18% May 05
FIZZ
$34.11
7.04% May 01
ADBE
$243.57
3.23% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE